2m 2m 2m 2m 2m 2m 2m
BRIDGEBIO PHARMA (BBIO)
NASDAQ
$81.50$0.00 (0.00%)
Price as of Aug 21, 2026 7:30 PM EDT- $15.9BMarket Cap
- 66.06%1-Year Change
- BiotechnologyIndustry
BRIDGEBIO PHARMA (BBIO)
$81.50$0.00 (0.00%)
Earnings Score
Valuation | BBIO | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -0 | ||
Growth | -0 | ||
Low Earnings Volatility | 1 |
Momentum Score
Valuation | BBIO | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | 25.65% | ||
12-Month Momentum | 65.10% | ||
3-Month Risk Adjusted Momentum | 126.51% | ||
12-Month Risk Adjusted Momentum | 139.24% |
True Yield
Valuation | BBIO | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | 1.44% | ||
Net Debt Paydown Yield | 5.02% |
Financial Health Score
Valuation | BBIO | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 4 |